Method for manufacturing a transglutaminase fusion compound, an antibody modifier comprising the fusion compound, and an antibody-drug complex using the fusion compound.
TW202631694APending Publication Date: 2026-08-01FUJIFILM CORP +1
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- FUJIFILM CORP
- Filing Date
- 2025-10-02
- Publication Date
- 2026-08-01
Smart Images
Figure TWG2TA001070684_001 
Figure TWG2TA001070684_002
Abstract
A method for manufacturing a transglutaminase fusion, an antibody modifier comprising the fusion, and an antibody-drug complex using the fusion, wherein the transglutaminase fusion system is derived from a transglutaminase precursor from an active microorganism linked to an antibody-binding peptide compound.
Need to check novelty before this filing date? Find Prior Art